Analystreport

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.

ZIOPHARM Oncology Inc  (ZIOP) 
Last ziopharm oncology inc earnings: 3/2 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ziopharm.com